Parallel Advisors’s Centessa Pharmaceuticals CNTA Stock Holding History

Parallel Advisors’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-15	Closed	-$596	–	3951
2026 Q1	$596	Buy	+15	New	+$384	﹤0.01%	3639

Parallel Advisors's CNTA Position: Q2 2026 in Review

Parallel Advisors sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 15 shares — an estimated $596 sold.

Parallel Advisors first reported a position in CNTA in Q1 2026 and held it in 1 quarter. The position peaked at $596 in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Parallel Advisors reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Parallel Advisors sold 15 Centessa Pharmaceuticals shares in Q2 2026, an estimated $596.
Parallel Advisors first reported a position in Centessa Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Parallel Advisors's Centessa Pharmaceuticals position peaked at $596 in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.